About 200 reports

  • What Is a Biosimilar?
  • WHAT IS A BIOSIMILAR?

Biosimilars in Immunology Report Code: GDHCHT## Published: February 2020 Healthcare TABLE OF CONTENTS (##/ ##) ##.

  • Biosimilar
  • Biocon Limited
  • Biogen Idec Inc.
  • Mylan Inc.
  • Pfizer Inc.

Global Biosimilars Partnering Terms and Agreements 2014 to 2019 Chapter ## – Introduction Chapter ## – Trends in Biosimilars dealmaking ##. ##.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • World
  • Demand

Global Biosimilars and Follow-On Biologics Market 2019-2029 ## Report Overview ##. ## Biosimilar Overview ##. ## Biosimilars Market Segmentation ##. ## Why You Should Read this Report ##. ## How this Report Delivers ##. ## Main Questions Answered by this Report ##. ## Who i

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Shares
  • Market Size

REST OF WORLD PART D: ANNEXURE ##.

  • Biosimilar
  • Europe
  • North America
  • World
  • Market Shares
  • WHAT IS A BIOSIMILAR?
  • What Is a Biosimilar?

Biosimilars in Oncology Report Code: GDHCHT## Published: August 2018 Healthcare TABLE OF CONTENTS (##/ ##) ##.

  • Biosimilar
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 ##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Size
  • 3. The Biosimilar Opportunity
  • 6. The Biosimilar Pipeline

THESE TABLES ARE SUMMARIZED IN Figure ##: Waves of Biosimilar Opportunity by Patent Expiry of Innovator Biologics.

  • Biosimilar
  • AbbVie Inc.
  • Alexion Pharmaceuticals, Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Approval process for biosimilars in US
  • Biosimilars market opportunities

Factors such as the patients and physician’s willingness to switch to biosimilars and the price advantage of biosimilars over biologics, will provide considerable growth opportunities to biosimilars manufactures.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • Market Size

Reddy’s Laboratories ##. ##. ## Intas Pharmaceuticals Ltd. ##. ##. ## STADA Arzneimittel AG ##. ##. ## Pfizer Inc. ##. ##. ## Apotex Inc. ##. ##. ## Teva Pharmaceutical Industries Ltd. ##. ##. ## Sandoz International GmbH ##. ##. ## BIOCAD ##. ##. ## Mylan ##. ##. ## F Hoffmann-La Roche List of Figures Figure ##: Global: On

  • Biosimilar
  • World
  • Demand
  • Forecast
  • Market Size

ZYDUS CADILA Chapter ## Appendix: Abbreviations List of Tables Summary Table : Global Market for Biosimilars, by Type, Through 2022 Table ## : List of Biosimilars Produced in E.

  • Biosimilar
  • Medical Biotechnology
  • World

Author Details Companies Mentioned ##.

  • Biosimilar
  • Medical Biotechnology
  • Monoclonal Antibody
  • World
  • Market Size

In particular, biosimilars are the less expensive option; however, biobetters have demonstrated to be more effective, even over longer periods of time as compared to biosimilars.

  • Biobetters
  • Biosimilar
  • Medical Biotechnology
  • Asia
  • Forecast

##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Size
  • Biosimilars in South Korea
  • Biosimilars in Brazil

UBS; ##-##.

  • Biosimilar
  • Amgen Inc.
  • Biocon Limited
  • Celltrion, Inc.
  • Pfizer Inc.
  • Biosimilars
  • Concerns with biosimilars

Familiarity with biosimilar IFX ##% of physicians reported having prescribed Remsima to at least one IBD patient & ##% of physicians have prescribed Inflectra to one of their IBD patients Physicians were generally more familiar with Remsima & Inflectra

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • United States
  • Remicade group

Biosimilars Market By Product, By Technology, By Indication, By Manufacturing Type, By Route of Administration, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2014-2024 Chapter ##.

  • Biosimilar
  • Europe
  • North America
  • World
  • Market Size

GLOBAL BIOSIMILAR MONOCLONAL ANTIBODIES FORECAST 2018-2028 ##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Shares
  • Market Size

Asia Pacific Biosimilar Insulin Glargine & Lispro Market, By End User, By Country, Competition, Forecast & Opportunities, 2024 ##.

  • Biosimilar
  • Chronic Disease
  • Medical Biotechnology
  • APAC
  • Market Shares

##.

  • Biosimilar
  • Medical Biotechnology
  • Monoclonal Antibody
  • World
  • Market Size

Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023 ## Preface ## Scope and Methodology ##. ## Objectives of the Study ##. ## Stakeholders ##. ## Data Sources ##. ##. ## Primary Sources ##. ##. ## Secondary Sources ##. ## Market Estimation ##. ##. ## Bottom-Up App

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Size

Biosimilar Commercial Strategies and Tactics CONTENTS ## OVERVIEW ## In order to realize the biosimilar opportunity, companies must understand the barriers to commercial success and leverage expertise from multiple stakeholder groups ## When firms begin to define a

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • Europe
  • United States

Japan Biosimilars- Landscape Today Outlook Tomorrow CHAPTER ##: EXECUTIVE SUMMARY CHAPTER ##: JAPANESE GOVERNMENT AND “CHUIKYO” INITIATIVES TO INCREASE BIOSIMILAR PENETRATION IN JAPAN • JBSA- How it will play important role for biosimilar penetration in Japan and overcome BS penetrat

  • Biosimilar
  • Medical Biotechnology
  • Japan
  • Market Description

Biosimilars Market Snapshot Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025 Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025 Table ## Global Oncology Biosimilars Marke

  • Biosimilar
  • Medical Biotechnology
  • APAC
  • World
  • Market Size
  • 7.2.2 PIPELINE BIOSIMILARS
  • PIPELINE BIOSIMILARS FOR AXIAL SPONDYLOARTHRITIS, 2019

BMJ SPECIALIST JOURNALS, ##(SUPPL ##), P.

  • Biosimilar
  • United States
  • Forecast
  • Novartis AG
  • Pfizer Inc.

US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025 ##.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • United States
  • Market Size
  • 7.2 BIOSIMILARS
  • SUMMARIZES THE APPROVAL AND LAUNCH DATES FOR THE MARKETED BIOSIMILARS IN THE 7MM.

PFIZER HAS ADDED SEVERAL ANTI-TNF BIOSIMILARS TO ITS ARSENAL: ONE ETANERCEPT BIOSIMILAR AND THREE INFLIXIMAB BIOSIMILARS.

  • Biosimilar
  • AbbVie Inc.
  • Amgen Inc.
  • Novartis AG
  • Pfizer Inc.

Biosimilars Real World Evidence: Proving the point ##.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • World
  • BIOSIMILARS
  • BIOGENERICS

TABLE OF CONTENTS (##/ ##) ##.

  • Biosimilar
  • Medical Biotechnology
  • Market Size
  • Supply
  • Remicade group

Biosimilars: EU Payer Perspectives ##.

  • Biosimilar
  • Medical Biotechnology
  • Europe

Commercialisaton of Biosimilars: Multifunctional teamwork for success ##.

  • Biosimilar
  • Medical Biotechnology
  • World